0002057780-25-000002.txt : 20250410 0002057780-25-000002.hdr.sgml : 20250410 20250410141907 ACCESSION NUMBER: 0002057780-25-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20250410 DATE AS OF CHANGE: 20250410 EFFECTIVENESS DATE: 20250410 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Treysta Medical Technologies Inc. CENTRAL INDEX KEY: 0002057780 ORGANIZATION NAME: EIN: 332998159 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-543371 FILM NUMBER: 25827818 BUSINESS ADDRESS: STREET 1: 3733 NORTHWEST 53RD LANE CITY: GAINESILLE STATE: FL ZIP: 32653 BUSINESS PHONE: 608-770-0658 MAIL ADDRESS: STREET 1: 3733 NORTHWEST 53RD LANE CITY: GAINESILLE STATE: FL ZIP: 32653 D 1 primary_doc.xml X0708 D LIVE 0002057780 Treysta Medical Technologies Inc. 747 SW 2nd Avenue STE 340 GAINESILVILLE FL FLORIDA 32601-6283 608-770-0658 DELAWARE None None Corporation true 2025 Nathan Wolf Zarnstorff 747 SW 2nd Avenue STE 340 Gainesville FL FLORIDA 32601-6283 Executive Officer Director Marcelo Buzzi 747 SW 2nd Ave STE 340 Gainesville FL FLORIDA 32601-6283 Executive Officer Director Biotechnology Decline to Disclose 06b false 2025-04-04 false true true false 0 150000 92500 57500 false 5 0 0 0 Proceeds will be used for working capital, which may include normal compensation to executive officers. false Treysta Medical Technologies Inc. Nathan Zarnstorff Nathan Zarnstorff President and CEO 2025-04-09